Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 194

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 194
---
 Tambour, Sonol, Supergas and GES.             |

Yours faithfully,

Moore Financial Consulting Ltd.

| Moore Financial Consulting |

| Teli.Valuation | November 2025Page 4 of 24 |

<div align='center'>Table of Contents</div>

| The                              
 Company                          |  5 |
| The                              
 Markets                          |  6 |
| Methodology                      | 11 |
| Valuation                        | 14 |
| Appendix                         
 – Benchmark Drugs and Treatments | 22 |

| Moore Financial Consulting |

| Teli.Valuation | November 2025Page 5 of 24 |

The Company

Telomir Pharmaceuticals, Inc. (“Telomir,”), is a pre-clinical-stage pharmaceutical development company.

Telomir-1 is a novel oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression. By modulating essential metal ions such as iron and copper, Telomir-1 may help protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and Age-related Macular Degeneration (AMD), as well as Type 2 Diabetes, Cancer, and Alzheimer’s disease.

Telomir holds the marketing and sales rights for the geographic region that includes the USA, Canada and Mexico (North America) of the products it develops. Teli holds the marketing and sales rights for the rest of the world.

| Moore Financial Consulting |

| Teli.Valuation | November 2025Page 6 of 24 |

The Markets

Age Related Macular Degeneration (AMD) 1, 2

General

Age-related macular degeneration (AMD) is an eye condition that causes blurring of your central vision. It occurs when the macula, the part of the retina responsible for sharp, straight-ahead vision, becomes damaged due to aging. The macula is located in the retina, the light-sensitive layer at the back of the eye.

AMD is a common disorder and one of the leading causes of vision loss among older adults. While it doesn’t lead to complete blindness, the loss of central vision can make daily activities like recognizing faces, reading, driving, or performing detailed tasks such as cooking or repairs more difficult.

The progression of AMD varies from person to person; it may advance slowly over many years or worsen more rapidly